| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.29 | 0.09 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.09 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.22 | 0.09 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.09 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.09 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.087 | 0.09 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.074 | 0.09 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.057 | 0.09 |